Relationship between serum complement and different lipid disorders

Clinical and Experimental Medicine

Volumn 2, Issue 1, 2002, Pages 33-38

  Pasqui, A L ^a   Puccetti, L ^a   Bova, G ^a   Di Renzo, M ^a   Bruni, F ^a   Pastorelli, M ^a   Palazzuoli, A ^a   Auteri, A ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Cholesterol; Complement system; Complement terminal complex C5b 9; HDL cholesterol; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; REGULATOR PROTEIN; TRIACYLGLYCEROL; APOLIPOPROTEIN A1; COMPLEMENT MEMBRANE ATTACK COMPLEX;

ADULT; AGED; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOTHELIUM CELL; EVALUATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; REGRESSION ANALYSIS; REGULATORY MECHANISM; BLOOD; COHORT ANALYSIS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; STATISTICS;

ADULT; AGED; APOLIPOPROTEIN A-I; CHOLESTEROL, HDL; COHORT STUDIES; COMPLEMENT MEMBRANE ATTACK COMPLEX; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; STATISTICS;

EID: 0036019537     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s102380200004     Document Type: Article

References (27)

1. Mechanisms of complement activation by crystalline cholesterol
2. Cholesterol and atheroma lipids activate complement and stimulates granulocytes. A possible mechanism for amplification of ischemic injury in atherosclerotic states
3. The complement system in atherosclerosis
4. Deposition of the terminal C5b-9 complex in infarcted areas of human myocardium
5. Kinetics and distribution of C9 and sC5b-9 in vivo: Effect of complement activation
6. Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions
7. Relationship between serum C3 levels and traditional risk factors for myocardial infarction
8. Correlations between serum lipids and complement components in adults without demonstrated atherosclerotic disease
9. Serum complement and familial combined hyperlipidemia
10. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis
11. Purification and characterization of acylation stimulating protein
12. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque
13. Deposition of the terminal C5b-9 complex in infarcted areas of human myocardium
14. The complement system in ischemic heart disease
15. Association of serum C3 levels with the risk of myocardial infarction
16. Metabolic response of acylation stimulating protein to an oral fat load
17. Impaired response in fibroblasts in patients with hyperapobetalipoproteinemia to acylation stimulating protein
18. The acute phase response
19. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities
20. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion
21. Fibrinolytic response in subjects with hypertriglyceridemia and low HDL cholesterol
22. Different mechanisms of fibrinolysis impairment among dyslipidemic subjects
23. High density lipoprotein as a protective factor against coronary heart disease
24. Atherosclerosis: Cell biology and lipoproteins
25. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins
26. Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): The presence of normal level of clusterin and the possible implication in the atherosclerosis
27. Clusterin in renal tissue: Preferential localisation with the terminal complement complex and immunoglobulin deposits in glomeruli